These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antagonism of footshock stress-induced inhibition of intracranial self-stimulation by naloxone or methamphetamine. Kamata K; Yoshida S; Kameyama T Brain Res; 1986 Apr; 371(1):197-200. PubMed ID: 3011201 [TBL] [Abstract][Full Text] [Related]
5. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168 [TBL] [Abstract][Full Text] [Related]
6. Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates. Stinus L; Winnock M; Kelley AE Psychopharmacology (Berl); 1985; 85(3):323-8. PubMed ID: 2860688 [TBL] [Abstract][Full Text] [Related]
7. Increase in mesolimbic electrical self-stimulation after chronic haloperidol: reversal by L-DOPA or lithium. Seeger TF; Gardner EL; Bridger WF Brain Res; 1981 Jun; 215(1-2):404-9. PubMed ID: 6790126 [TBL] [Abstract][Full Text] [Related]
8. Differential antagonism by naloxone of inhibitory effects of haloperidol and morphine on brain self-stimulation. Wauquier A; Niemegeers CJ; Lal H Psychopharmacologia; 1974; 37(4):303-10. PubMed ID: 4859277 [No Abstract] [Full Text] [Related]
9. Pentobarbital induces a naloxone-reversible decrease in mesolimbic self-stimulation threshold. Seeger TF; Carlson KR; Nazzaro JM Pharmacol Biochem Behav; 1981 Oct; 15(4):583-6. PubMed ID: 7291262 [TBL] [Abstract][Full Text] [Related]
10. Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation. van Wolfswinkel L; van Ree JM Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):84-92. PubMed ID: 4047179 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity. Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355 [TBL] [Abstract][Full Text] [Related]
13. Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol. Davis KL; Hollister LE; Fritz WC Life Sci; 1978 Oct; 23(15):1543-8. PubMed ID: 723433 [No Abstract] [Full Text] [Related]
14. Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity. Seeger TF; Gardner EL Brain Res; 1979 Oct; 175(1):49-57. PubMed ID: 114275 [TBL] [Abstract][Full Text] [Related]
15. 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. Pei Q; Zetterström T; Leslie RA; Grahame-Smith DG Eur J Pharmacol; 1993 Jan; 230(1):63-8. PubMed ID: 8381355 [TBL] [Abstract][Full Text] [Related]
16. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol. Ahtee L; Kaakkola S Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219 [TBL] [Abstract][Full Text] [Related]
17. Ontogeny of the endorphinergic and dopaminergic modulation on the immobility reflex elicited by clamping in rats. de la Cruz F; Russek M; Junquera J Int J Psychophysiol; 1990 Sep; 9(2):171-7. PubMed ID: 2228751 [TBL] [Abstract][Full Text] [Related]
19. Neuropeptide-dopamine interactions. III. Cyclo(His-Pro) and persistence of dopaminergic supersensitivity on withdrawal from one year continuous neuroleptic treatment. Prasad C Schizophr Res; 1988; 1(6):411-5. PubMed ID: 2908706 [TBL] [Abstract][Full Text] [Related]
20. Catecholamines and endogenous opioids in ventral tegmental self-stimulation reward. van Wolfswinkel L; Seifert WF; van Ree JM Pharmacol Biochem Behav; 1988 Jul; 30(3):589-95. PubMed ID: 3211968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]